LICENSE AGREEMENT by and between BIOCRYST PHARMACEUTICALS, INC. and SEQIRUS UK LIMITED Dated as of June 16, 2015License Agreement • August 7th, 2015 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This LICENSE AGREEMENT, including any schedules, annexures, attachments or exhibits hereto (this “Agreement”) is entered into as of June 16, 2015 (the “Effective Date”) by and between BIOCRYST PHARMACEUTICALS, INC., a corporation organized and existing under the laws of the State of Delaware having offices at 4505 Emperor Blvd., Suite 200, Durham, NC 27703 (“BioCryst”), and SEQIRUS UK LIMITED, a limited company organized under the laws of the United Kingdom, having a business address at 100 New Bridge Street, London, England, EC4V 6JA (“CSL”). BioCryst and CSL are each referred to herein by name or individually as a “Party” or collectively as the “Parties.”
NOVATION AGREEMENTNovation Agreement • August 7th, 2015 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Albert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University, of 1300 Morris Park Ave, Bronx, NY 10461,United States of America; BioCryst Pharmaceuticals Inc. of 4505 Emperor Blvd, Suite 200, Durham, NC27703, United States of America (each a Continuing Party and together the Continuing Parties);
NOVATION AGREEMENTNovation Agreement • August 7th, 2015 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Albert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University, of 1300 Morris Park Ave, Bronx, NY 10461,United States of America (AECOM); BioCryst Pharmaceuticals Inc of 4505 Emperor Blvd, Suite 200, Durham, NC27703, United States of America (BioCryst); Mundipharma International Corporation Limited (the permitted assignee of Mundipharma International Holdings Limited) of Mundipharma House, 14 Par-la Ville Road, Hamilton, Bermuda HMJX (Mundipharma), (each a Continuing Party and collectively, the Continuing Parties);
